Abstract
Gestational diabetes mellitus (GDM) and type 2 diabetes mellitus (DM2) are suggested to be caused by the same metabolic disorder. Defects in gut hormone-dependent regulation of beta-cell function (entero-insular axis) have been proposed to contribute to the pathogenesis of DM2. The aim of study was to evaluate whether an impaired secretion of glucagon-like peptide-1 (GLP-1) and/or glucose-dependent insulinotropic polypeptide (GIP) could play a role in the development of carbohydrate disorders during pregnancy.
Originalsprog | Engelsk |
---|---|
Tidsskrift | Gynecological Endocrinology |
Vol/bind | 23 |
Udgave nummer | 1 |
Sider (fra-til) | 58-62 |
Antal sider | 5 |
ISSN | 0951-3590 |
Status | Udgivet - 1 jan. 2007 |